GlassScriptPhysician profile
Jessica Murphy
NPI 1780002071
$1,623.15
in general payments reported to CMS, 2019-2025
16 companies · $584 in 2025
The $584 reported for 2025 was more than what 93% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $98.15 · 2022: $136 · 2023: $449 · 2024: $356 · 2025: $584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,389.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $271.29 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $262.43 | 2021-2025 | Vaxneuvance, Vaxelis, M-M-R II |
| Glaxosmithkline, LLC. | $219.14 | 2021-2024 | Bexsero |
| Cranial Technologies, INC | $157.59 | 2022-2025 | Doc Band |
| Alexion Pharmaceuticals, INC. | $121.82 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $120.62 | 2025 | Dupixent |
| Biogen, INC. | $96.21 | 2023 | Spinraza |
| Pfizer INC. | $82.76 | 2023-2024 | |
| Biomarin Pharmaceutical INC. | $67.85 | 2023-2024 | Voxzogo 1.2mg |
| Phadia US INC. | $47.30 | 2024 | Immunocap |
| Seqirus USA INC | $41.30 | 2025 | Flucelvax |
| Supernus Pharmaceuticals, INC. | $29.88 | 2025 | Qelbree |
| Cleerly, INC. | $27.35 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Sanofi-Aventis U.S. LLC | $27.19 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $25.83 | 2022-2024 | Kristalose |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $24.59 | 2025 | Daybue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.